High materiality9/10
Rapport Therapeutics (RAPP) Reiterated at Market Outperform by Citizens on Positive Ph2 Results
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS reiterates Market Outperform with a $80 target; price $41.47.
- UBS reiterates Market Outperform; target $80; price $41.47.
Key facts
- 01
Target: $80
- 02
Posted price: $41.47
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.